Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study.
Marco A CimminoMassimiliano ParodiFrancesca BarbieriStefano BombardieriGiuseppe ZampognaAnnamaria IagnoccoAlberto BatticciottoLuca Maria SconfienzaLuigi SinigagliaFabrizio De BenedettiFabiola AtzeniPiercarlo Sarzi-PuttiniPublished in: Biologics : targets & therapy (2020)
TCZ in combination with DMARDs improved wrist synovitis, BME and clinical parameters, without any progression in bone erosions. The RAMRIS for synovitis rapidly improved from as early as two weeks after the first TCZ infusion. (Funded by F. Hoffmann-La Roche; ACTRACE EudraCT No. 2009 012185-32).
Keyphrases
- rheumatoid arthritis
- rheumatoid arthritis patients
- disease activity
- magnetic resonance imaging
- contrast enhanced
- bone mineral density
- low dose
- ankylosing spondylitis
- interstitial lung disease
- magnetic resonance
- combination therapy
- systemic lupus erythematosus
- soft tissue
- postmenopausal women
- replacement therapy
- systemic sclerosis
- smoking cessation